Cerecor Inc. (CERC)

3.91 0 (0%)

IEX Real-Time Price

August 16, 2018 EST.

NASDAQ Capital Market : Healthcare

Prev Close 3.91

Price Open 4.09

Volume: 67,806

Avg Volume: 47,877

Market Cap: 132.33M

P/E Ratio 16.29

52 Wk Range 0.5238-5.739



CERC Short Interest Statistics


Report Date
Float Share
Short Interest
Short Ratio
Short % to Float

2018-07-31
30.72M
229,019
4.73
0.75%

2018-07-13
30.72M
242,586
3.48
0.79%

2018-06-29
30.72M
282,247
3.26
0.92%

2018-06-15
30.73M
211,127
1.87
0.69%




CERC Earning Report


Report Date
Fiscal Period
Announce Time
Estimated EPS(#)
Actual EPS
Surprise Dollar

2018-05-11
Q1 2018
N/A
0.00 (0)
-0.07
0.00

2018-05-08
Q1 2018
N/A
0.00 (0)
0.00
0.00

2018-04-03
Q4 2017
N/A
0.00 (0)
0.00
0.00

2018-04-02
Q4 2017
N/A
0.00 (0)
-0.11
0.00

News

Cerecor reports Q2 results (2018-08-09 06:33 SeekingAlpha)

Cerecor (NASDAQ: CERC ): Q2 EPS of -$0.19 More news on: Cerecor, Earnings news and commentary, Healthcare stocks news, , Read more …

 


Statistics

Shares Outstanding: 33.84M

Top 15 Institution Percent: 92.10

Price To Sales: 3.76

Price To Book: 7.15

Revenue: 25.04M

Gross Profit: N/A

Cash: 23.96M

Debt: N/A

Return On Assets: 4.81

Return On Equity: 14.68

Profit Margin: 15.05

Price History

Beta: 1.24

50-day Moving Avg: 4.49

200-day Moving Avg: 3.59

YTD Change: 17.42

5-day Change: -12.33

1-month Change: -8.22

3-month Change: 4.83

6-month Change: -3.22

1-year Change: N/A

Revenue Per Share: 1.00

Revenue Per Employee: 658884.00



Dividend

Dividend Yield: -

EX-Dividend Date: -

Dividend Rate: -


Company Profile

Name: Cerecor Inc.

Exchange: NASDAQ Capital Market

Industry: Biotechnology

Sector: Healthcare

Website: http://www.cerecor.com

Cerecor Inc is a clinical stage biopharmaceutical company which is engaged in developing drug candidates for patients with neurological and psychiatric disorders. The company owns a right to COMTi platform.